Hospi

Hospi is a biotechnology and health care startup that is dedicated to innovating high-impact medical devices to enhance patient comfort and wellbeing while easing caregiver burden and reducing costs. Founded in 2012, the company operates with the vision of improving the quality of life by creating practical, impactful medical devices that boost patient comfort and wellbeing, lessen caregiver workload, and lower costs. Hospi Corporation's first product, the Macy Catheter®, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available in the United States. Invented by Hospi co-founder Brad Macy, a hospice nurse with 20 years of experience, the Macy Catheter addresses the need for improved patient comfort and wellbeing. It is a straightforward, patented, and innovative medical device designed for the discreet and comfortable rectal administration of liquids or medications. This route of administration is relevant but underutilized in hospice, palliative care, and home health settings, especially for managing symptoms when a patient has difficulty swallowing or when the oral route is not feasible. The startup received a significant $3.49M Venture Round investment on 29 May 2020, demonstrating confidence from investors in its mission and potential impact in the healthcare industry. Despite not having information on the specific investors involved in the last investment round, the company's commitment to addressing unmet needs in patient care through innovative medical devices makes it a promising prospect for investors looking to support advancements in healthcare technology and patient well-being.